Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laurus Bio is a leading Indian integrated biomanufacturing organization specializing in precision fermentation and recombinant technology. It develops animal-origin-free recombinant proteins and growth factors for use across biopharma manufacturing (biologics/insulin/vaccines), cell/gene therapy media supplements, food tech/cultured meat applications, health/nutrition/personal care sectors. The company operates at commercial scale with significant fermentation capacity (>180–240 kL) serving global clients as a CDMO partner. It was formerly known as Richcore Lifesciences before being acquired by Laurus Labs in 2020–2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laurus Bio.